Sherry Dr Bradford

Sherry Dr Bradford is a highly experienced professional in the fields of personalized medicine and dermatology. As the President of AccuTheranostics, Inc. since January 2005, Sherry has focused on cancer treatment, specifically chemo sensitivity and resistance, while also engaging in research and clinical laboratories. In addition, Sherry co-founded SS Formulations in July 2013, where innovative dermatology products including BrillyantSkin(R) anti-aging products were developed. Sherry served as an Adjunct Professor at ECC South from September 2002 to January 2018, teaching Anatomy and Physiology. Furthermore, Sherry founded the PROI Cancer Foundation in August 2005 to support cancer research and patient care. Sherry holds a Doctor of Philosophy (PhD) in Medical Biochemistry from the University at Buffalo.